Lọc tín hiệu
VHE

VHE

Viet Nam Herbs and Foods
PharmaceuticalsHNX
Same sector:AGPAMPBCHBCPBIOCDPCNCDANDBDDBM
2.800
+3,70%
2026-10-19

Fundamental Analysis

44 / 100BRubric: Manufacturing
Quarterly resultsRelative Valuation
CriterionLatest Q EPS growth (YoY)Avg EPS growth, last 3 (YoY)Quarters with EPS growthRevenue growth (YoY)Gross margin change (pp, YoY)Net margin change (pp, YoY)Return on Equity (TTM)Financial health (Debt/Equity)Valuation (P/E vs 5-yr median)Revenue (bn)Rev YoYNPAT (bn)NPAT YoYP/E5-Year Median P/EP/E vs. 5-Year Median
Value-87.7%+243.0%2 / 3-39.7%-1.70 pp-4.26 pp+3.1%0.628.03128−39,7%1,4−87,7%8.0356.29−85,7%
Pts012804001212
Valuation annotation:Price: 2.800 (close price on 2026-10-19)EPS (TTM): 348,8

Financial charts

1.Revenue & growth

VND bn128Q2/26

1.Revenue & growth

VND bn128Q2/26

2.Profit & growth

VND bn1,39Q2/26

3.Profit mix (Penman)

VND bn14,7Q2/26

4.Margins & cost structure

%9.0%Q2/26

5.Returns & cash cycle

% · days4.4%Q2/26

6.Earnings quality & cash

VND bn-30,0Q2/26

7.Asset structure

VND bn627Q2/26

8.Funding & debt health

VND bn · times627Q2/26

9.Revenue backlog

VND bn0,06Q2/26

10.Valuation

times · %8,0×Q2/26

11.EPS growth & dilution warning (CANSLIM)

VND per share; growth in %42Q2/26
Adjusted EPS growth, latest quarter
-87.7%
Average adjusted EPS growth, 3 quarters
243%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%

Source: vnstockData through Q2/26